David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
Kennedy Institute of Ethics Journal 14 (4):361-368 (2004)
: Controversy has surrounded the institutions that facilitate discussion and regulation of American biomedical research for years. Recent challenges to the legitimacy of the President's Council on Bioethics have been focused on stem cell research. These arguments represent an opportunity to reconsider the legislation under which stem cell research is regulated, as well as to consider preexisting bodies like the Recombinant DNA Advisory Committee and National Bioethics Advisory Commission. This paper proposes a Federal Life Sciences Policy Commission, a novel commission with advisory and regulatory powers that would benefit from the positive and negative lessons learned under the legislation that currently shapes the formation and institutional characteristics of advisory bodies in the United States. The Federal Life Sciences Policy Commission would have institutional independence not present in previous advisory bodies, while maintaining the tradition of broad societal representation and thoughtful discourse that has developed in the United States
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
|Through your library|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Jane Maienschein, Mary Sunderland, Rachel A. Ankeny & Jason Scott Robert (2008). The Ethos and Ethics of Translational Research. American Journal of Bioethics 8 (3):43 – 51.
Jean-Paul Gaudillière (2006). Normal Pathways: Controlling Isotopes and Building Biomedical Research in Postwar France. [REVIEW] Journal of the History of Biology 39 (4):737 - 764.
Patrick L. Taylor (2005). The Gap Between Law and Ethics in Human Embryonic Stem Cell Research: Overcoming the Effect of U.S. Federal Policy on Research Advances and Public Benefit. Science and Engineering Ethics 11 (4):589-616.
David B. Resnick (1999). Privatized Biomedical Research, Public Fears, and the Hazards of Government Regulation: Lessons From Stem Cell Research. [REVIEW] Health Care Analysis 7 (3):273-287.
Patrick L. Taylor (2009). Scientific Self-Regulation—so Good, How Can It Fail? Science and Engineering Ethics 15 (3):395-406.
Glenn McGee & Arthur L. Caplan (1999). The Ethics and Politics of Small Sacrifices in Stem Cell Research. Kennedy Institute of Ethics Journal 9 (2):151-158.
Laurie Zoloth (2002). Stem Cell Research: A Target Article Collection Part I - Jordan's Banks, a View From the First Years of Human Embryonic Stem Cell Research. American Journal of Bioethics 2 (1):3 – 11.
Celia B. Fisher, Susan Z. Kornetsky & Ernest D. Prentice (2007). Determining Risk in Pediatric Research with No Prospect of Direct Benefit: Time for a National Consensus on the Interpretation of Federal Regulations. American Journal of Bioethics 7 (3):5 – 10.
Cynthia B. Cohen (2005). Promises and Perils of Public Deliberation: Contrasting Two National Bioethics Commissions on Embryonic Stem Cell Research. Kennedy Institute of Ethics Journal 15 (3):269-288.
Added to index2009-01-28
Total downloads9 ( #173,442 of 1,413,407 )
Recent downloads (6 months)5 ( #41,910 of 1,413,407 )
How can I increase my downloads?